| Product Code: ETC5359050 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North Korea Buprenorphine Market Overview |
3.1 North Korea Country Macro Economic Indicators |
3.2 North Korea Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 North Korea Buprenorphine Market - Industry Life Cycle |
3.4 North Korea Buprenorphine Market - Porter's Five Forces |
3.5 North Korea Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 North Korea Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 North Korea Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North Korea Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of buprenorphine as an effective treatment for opioid addiction. |
4.2.2 Government initiatives to address the opioid crisis and promote access to medication-assisted treatment. |
4.2.3 Rising prevalence of opioid addiction and the need for alternative treatment options in North Korea. |
4.3 Market Restraints |
4.3.1 Limited availability and access to buprenorphine due to regulatory restrictions. |
4.3.2 Stigma associated with medication-assisted treatment for opioid addiction. |
4.3.3 Lack of healthcare infrastructure and trained professionals to support buprenorphine treatment programs. |
5 North Korea Buprenorphine Market Trends |
6 North Korea Buprenorphine Market Segmentations |
6.1 North Korea Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 North Korea Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 North Korea Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 North Korea Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 North Korea Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 North Korea Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 North Korea Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 North Korea Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 North Korea Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 North Korea Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 North Korea Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 North Korea Buprenorphine Market Import-Export Trade Statistics |
7.1 North Korea Buprenorphine Market Export to Major Countries |
7.2 North Korea Buprenorphine Market Imports from Major Countries |
8 North Korea Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering buprenorphine treatment. |
8.2 Patient retention rates in buprenorphine treatment programs. |
8.3 Percentage of opioid addiction cases being treated with buprenorphine. |
8.4 Rate of successful treatment outcomes with buprenorphine. |
9 North Korea Buprenorphine Market - Opportunity Assessment |
9.1 North Korea Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 North Korea Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 North Korea Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 North Korea Buprenorphine Market - Competitive Landscape |
10.1 North Korea Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 North Korea Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |